Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Eldred Kary. Officer active across 1 company, notably Galectin Therapeutics INC. In total, 12 disclosures have been logged. Split: 12 buys · 0 sell. Total volume traded: €27k. Activity tracked since 25 January 2023. The latest transaction was filed on 6 February 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Eldred Kary
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1,300 shares@ US$1.116.0% of flowCommon StockSEC:0001133416-23-000006:0
Canonical exit: 25 Apr 2023 (T+90)
12 of 12 declarations
About Eldred Kary
ELDRED KARY is a declarant linked to Galectin Therapeutics INC, where he is a Director. The 12 filings recorded, all within the sampled recent filings, cover the period from 2023-01-26 to 2026-02-09 and show acquisitions only, with total buys of EUR 27376 and no sells.